JP2022533976A5 - - Google Patents

Info

Publication number
JP2022533976A5
JP2022533976A5 JP2021568646A JP2021568646A JP2022533976A5 JP 2022533976 A5 JP2022533976 A5 JP 2022533976A5 JP 2021568646 A JP2021568646 A JP 2021568646A JP 2021568646 A JP2021568646 A JP 2021568646A JP 2022533976 A5 JP2022533976 A5 JP 2022533976A5
Authority
JP
Japan
Prior art keywords
omv
pharmaceutical formulation
formulation according
pharmaceutical
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021568646A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022533976A (ja
Filing date
Publication date
Priority claimed from GBGB1906830.3A external-priority patent/GB201906830D0/en
Application filed filed Critical
Publication of JP2022533976A publication Critical patent/JP2022533976A/ja
Publication of JP2022533976A5 publication Critical patent/JP2022533976A5/ja
Pending legal-status Critical Current

Links

JP2021568646A 2019-05-15 2020-05-15 バクテリア由来の外膜小胞の供給 Pending JP2022533976A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1906830.3 2019-05-15
GBGB1906830.3A GB201906830D0 (en) 2019-05-15 2019-05-15 Delivery of bacteria-derived outer membrane vesicles
PCT/GB2020/051204 WO2020229846A2 (en) 2019-05-15 2020-05-15 Delivery of Bacteria-Derived Outer Membrane Vesicles

Publications (2)

Publication Number Publication Date
JP2022533976A JP2022533976A (ja) 2022-07-27
JP2022533976A5 true JP2022533976A5 (cg-RX-API-DMAC10.html) 2023-03-30

Family

ID=67384734

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021568646A Pending JP2022533976A (ja) 2019-05-15 2020-05-15 バクテリア由来の外膜小胞の供給

Country Status (5)

Country Link
US (2) US12527852B2 (cg-RX-API-DMAC10.html)
EP (1) EP3969042A2 (cg-RX-API-DMAC10.html)
JP (1) JP2022533976A (cg-RX-API-DMAC10.html)
GB (1) GB201906830D0 (cg-RX-API-DMAC10.html)
WO (1) WO2020229846A2 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114672507B (zh) * 2022-03-22 2024-04-16 浙江工业大学 一种可递呈多个异源肽或蛋白质的细菌外膜囊泡及其构建方法和应用
CN119875903B (zh) * 2025-01-13 2025-09-19 南昌大学 一种基于细菌外膜囊泡的抗生素载体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE040658T2 (hu) * 2010-04-07 2019-03-28 California Inst Of Techn Vivõanyag vegyület mukózus membránhoz juttatásához és kapcsolódó készítmények, eljárások és rendszerek
GB201607510D0 (en) * 2016-04-29 2016-06-15 Inst Of Food Res The Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMV) for delivery to the GI-tract
GB201817194D0 (en) 2018-10-22 2018-12-05 Quadram Inst Bioscience Gut bacteria derived microvesicles for vaccine delivery

Similar Documents

Publication Publication Date Title
US20230390381A1 (en) Immunogenic combinations
HRP20140765T1 (hr) Vektori i konstrukti za prijenos antigena gripe
TWI329130B (en) Functionally reconstituted viral membranes containing adjuvant
CN101212983B (zh) 包含α-半乳糖基神经酰胺作为佐剂的用于鼻内施用的疫苗组合物
KR101342641B1 (ko) 폴리감마글루탐산-키토산 나노입자를 함유하는 면역보강제 조성물
CN101616687B (zh) 非特异性免疫刺激剂
JP2000513352A (ja) リポソームインフルエンザワクチンの組成物および方法
CN112755180B (zh) 一种通用的细菌疫苗的制备方法和应用
JP2014508734A5 (cg-RX-API-DMAC10.html)
CA2791661C (en) Mucosal vaccines
BRPI0707556A2 (pt) veÍculo para vacina
EP3471705A1 (en) Method and apparatus for preparing a micro-particles composition
CN109069424A (zh) 脂质体疫苗
JPH05504756A (ja) 免疫刺激性を有する組成物と、そのヒトと獣医学用医薬への応用
Fukuyama et al. A molecular mucosal adjuvant to enhance immunity against pneumococcal infection in the elderly
De Moreno de LeBlanc et al. Oral administration of L. casei CRL 431 increases immunity in bronchus and mammary glands
CN102724998A (zh) 用于引发特异性免疫应答以治疗病毒感染和其他病症的具有肽佐剂的疫苗
Li et al. Study on the immunity protection of 14-3-3–MPLA–liposome vaccine against cystic echinococcosis in mice
EP3969042A2 (en) Delivery of bacteria-derived outer membrane vesicles
EP3858382A1 (en) Mucosal adjuvant
CU23377A1 (es) Metodo para la incorporacion de antigenos en vesiculas de membrana externa de bacterias y formulaciones resultantes
EP4431111A1 (en) Probiotic as vaccine immunoadjuvant
Nakahashi-Ouchida et al. Nanodelivery vehicles for mucosal vaccines
ZHANG et al. Immunogenicity and efficacy of liposome-encapsulated influenza split vaccine in BALB/c mice
Wang et al. Manganese zoledronate sublingual nano-vaccine potentiates tumor inhibition and oral micro-ecology rebalance through mucosal and trained immunity